SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 59.78 |
Enterprise Value ($M) | 61.89 |
Book Value ($M) | 22.55 |
Book Value / Share | 1.61 |
Price / Book | 2.65 |
NCAV ($M) | -16.59 |
NCAV / Share | -1.19 |
Price / NCAV | -3.60 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.13 |
Return on Assets (ROA) | -0.08 |
Return on Equity (ROE) | -0.24 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.03 |
Current Ratio | 1.15 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 36.45 |
Assets | 75.58 |
Liabilities | 53.04 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 37.87 |
Operating Income | -6.43 |
Net Income | -6.48 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -0.61 |
Cash from Investing | 0.06 |
Cash from Financing | 0.20 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Kazimi A J | 40.80 | -0.89 | |
13G | Integrated Core Strategies (us) Llc | 8.80 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
2,571 | 22,939 | 11.21 | |
1,791 | 13,517 | 13.25 | |
5,247 | 31,656 | 16.58 | |
1,132 | 45,064 | 2.51 | |
(click for more detail) |
Similar Companies | |
---|---|
CGON – CG Oncology, Inc. | COGT – Cogent Biosciences, Inc. |
COLL – Collegium Pharmaceutical, Inc. | CRBU – Caribou Biosciences, Inc. |
CRGX – CARGO Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io